6W41
Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody CR3022
- PDB DOI: https://doi.org/10.2210/pdb6W41/pdb
- Classification: IMMUNE SYSTEM/VIRAL PROTEIN
- Organism(s): Homo sapiens, Severe acute respiratory syndrome coronavirus 2
- Expression System: Homo sapiens, Trichoplusia ni
- Mutation(s): No 
- Deposited: 2020-03-09 Released: 2020-03-25 
- Funding Organization(s): National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID), Bill & Melinda Gates Foundation
Experimental Data Snapshot
- Method: X-RAY DIFFRACTION
- Resolution: 3.08 Å
- R-Value Free: 0.243 
- R-Value Work: 0.223 
- R-Value Observed: 0.224 
This is version 1.6 of the entry. See complete history. 
Macromolecules
Find similar proteins by:
(by identity cutoff) | 3D Structure
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
CR3022 Fab heavy chain | A [auth H] | 222 | Homo sapiens | Mutation(s): 0  | |
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Find similar proteins by:
(by identity cutoff) | 3D Structure
Entity ID: 2 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
CR3022 Fab light chain | B [auth L] | 221 | Homo sapiens | Mutation(s): 0  | |
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Find similar proteins by:
(by identity cutoff) | 3D Structure
Entity ID: 3 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Spike protein S1 | 231 | Severe acute respiratory syndrome coronavirus 2 | Mutation(s): 0  Gene Names: S, 2 | ||
UniProt | |||||
Find proteins for P0DTC2 (Severe acute respiratory syndrome coronavirus 2) Explore P0DTC2  Go to UniProtKB:  P0DTC2 | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P0DTC2 | ||||
Sequence AnnotationsExpand | |||||
|
Small Molecules
Ligands 3 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
NAG Query on NAG | G [auth C] | 2-acetamido-2-deoxy-beta-D-glucopyranose C8 H15 N O6 OVRNDRQMDRJTHS-FMDGEEDCSA-N | |||
SO4 Query on SO4 | E [auth L], F [auth L] | SULFATE ION O4 S QAOWNCQODCNURD-UHFFFAOYSA-L | |||
GOL Query on GOL | D [auth L] | GLYCEROL C3 H8 O3 PEDCQBHIVMGVHV-UHFFFAOYSA-N |
Experimental Data & Validation
Experimental Data
- Method: X-RAY DIFFRACTION
- Resolution: 3.08 Å
- R-Value Free: 0.243 
- R-Value Work: 0.223 
- R-Value Observed: 0.224 
- Space Group: P 41 2 2
Unit Cell:
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 147.535 | α = 90 |
b = 147.535 | β = 90 |
c = 200.156 | γ = 90 |
Software Name | Purpose |
---|---|
HKL-2000 | data scaling |
PHENIX | refinement |
PDB_EXTRACT | data extraction |
HKL-2000 | data reduction |
PHASER | phasing |
Entry History & Funding Information
Deposition Data
- Released Date: 2020-03-25  Deposition Author(s): Yuan, M., Wu, N.C., Zhu, X.Y., Wilson, I.A.
Funding Organization | Location | Grant Number |
---|---|---|
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID) | United States | K99 AI139445 |
Bill & Melinda Gates Foundation | United States | OPP1170236 |
Revision History (Full details and data files)
- Version 1.0: 2020-03-25
Type: Initial release - Version 1.1: 2020-04-08
Changes: Database references - Version 1.2: 2020-04-15
Changes: Database references - Version 1.3: 2020-05-06
Changes: Database references, Source and taxonomy, Structure summary - Version 1.4: 2020-05-20
Changes: Database references - Version 1.5: 2020-07-29
Type: Remediation
Reason: Carbohydrate remediation
Changes: Data collection, Derived calculations, Structure summary - Version 1.6: 2023-10-18
Changes: Data collection, Database references, Refinement description, Structure summary